Medical research

Our top picks from the month’s research, business and policy news across the cannabis industry

Could cannabinol (CBN) hold promise as a future neurotherapeutic for Alzheimer’s disease and other age-related neurodegenerative disorders?

A celebration of the industry’s favourite holiday

Richard van Breemen tells us about his latest research showing that CBD-A and CBG-A are effective cell entry inhibitors of SARS-CoV-2

Could cannabis use really be linked to improved sexual function in young adults?

New data sheds light on the role of cannabis in sleep–wake regulation

It’s been a busy start to the year for cannabis science, with new research, policies and business announcements hitting the headlines.

Does CBD have the potential to reduce inflammation without hampering tissue regeneration?

Looking back on 12 months of top stories from across the cannabis science world

False self-reporting is a big issue in clinical studies. Could biomarkers be the answer?